Hey godiva, I firmly believe in knowing your customer when doing business. I also go by knowing your management when investing in ASX companies. PH has forever stated Bio's are to be offloaded in phase two positions. Lesslie, unless having been gagged is not out and about. Whilst I'm excited news will drop in the last quarter. Lesslie, not singing from the rooftops' following another FDA Orphan study grant, has me believing they have bigger fish frying. The timing makes sense, as deals are best done in private before data creates too much competition. PH could be cutting a deal, and I'm not talking about CR's.
Sit tight, something huge is about to be rolled out for mine. I wouldn't be making any price estimates. Will either be bust or $ for mine !
-GO IMU!
Not Financial Advice - Opinions Only - DYOR!
IMU Price at posting:
5.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)